TissueScan, Breast Cancer cDNA Array I

SKU
BCRT301
TissueScan Breast Cancer Tissue qPCR Panel I (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues
New! ER, PR and HER2 in Clinical Info.
  $1,870.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Breast Cancer cDNA Array I
Clinical Info
Diagnosis Category Breast Cancer
Tissue Breast
Shipping Ambient
Description TissueScan Breast Cancer Tissue qPCR Panel I (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues
New! ER, PR and HER2 in Clinical Info.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

The Hypertension Related Gene G-Protein Coupled Receptor Kinase 4 Contributes to Breast Cancer Proliferation
Yue, Tran, Wang et al
Breast Cancer (Auckl) (2021) 15, 11782234211015753 DOI: 10.1177/11782234211015753
Cited by 15
AI Summary: OriGene products contributed to this study by providing the GRK4 cDNA (Cat# SC119498) for re-expression experiments and lentiviral shRNA constructs (Cat# TL313236V) for GRK4 knockdown in breast cancer cell lines, enabling the researchers to assess the functional role of GRK4 in breast cancer proliferation.
FigureFigureFigure
A CTGF-RUNX2-RANKL Axis in Breast and Prostate Cancer cells Promotes Tumor Progression in Bone
Kim, Kim, Jung et al
J. Bone Miner. Res. (2019) 35 (1), 155-166 DOI: 10.1002/jbmr.3869
AI Summary: OriGene's pathologist-verified breast cancer tissue cDNA arrays were used in this study to analyze CTGF and RANKL expression levels in human tumor samples by real-time PCR.
Snippet: analyses. For the experiments shown in Fig. 7C, cDNA arrays prepared from pathologist- verified breast cancer tissues were purchased from OriGene (Rockville, MD, USA). qPCR plates were coated with cDNA and analyzed by real-time PCR using human CTGF primers;- analyses. For the experiments shown in Fig. 7C, cDNA arrays prepared from pathologist- verified breast cancer tissues were purchased from ...
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
Weng, Tseng, Chen et al
Mol. Cancer (2019) 18 (1), 42 DOI: 10.1186/s12943-019-0988-0
AI Summary: OriGene’s TissueScan Breast Cancer Tissue qPCR Panels (I, III, and IV) were used in this study to quantify MCT-1, IL-6, and IL-6R mRNA levels in breast cancer tissues, enabling analysis of gene expression associated with cancer progression and prognosis.
Snippet: cancer patients. The survival curve was exported using GraphPad Prism software. MCT-1, IL-6 and IL-6R mRNA levels were quantified by using TissueScan Breast Cancer Tissue qPCR Panels (I, III and IV) (OriGene Technologies, Inc., Rockville, MD). Relative mRNA levels were calculated: ΔΔCT = ΔCt cancer-ΔCt normal tissue. The fold change in the gene was calculated using the formula 2−ΔΔCT.;... cancer p...
FigureFigureFigure
A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer
Soh, Lim, Samy et al
Exp Mol Pathol (2018) 105 (3), 364-370 DOI: 10.1016/j.yexmp.2018.10.010
Cited by 28
AI Summary: In this study, OriGene’s Human AKAP12 siRNA (SR304092) and Human AKAP12 qPCR primers (HP209406) were used to specifically knock down and measure AKAP12 expression, respectively, enabling the authors to investigate AKAP12’s role in inhibiting breast cancer cell migration.
Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3
Kim, Shin, Lee et al
Cell Rep (2018) 24 (1), 224-237 DOI: 10.1016/j.celrep.2018.06.020
AI Summary: OriGene's TissueScan cDNA arrays were used to analyze the expression of mH2A1.2 and LOX in breast cancer tissues by qRT-PCR, enabling the study of their correlation in the regulation of osteoclastogenesis.
Snippet: (D) Breast cancer TissueScan cDNA arrays (OriGene) were analyzed for mH2A1.2 (upper) and LOX (lower) expression by qRT-PCR. The scatterplot diagram on the right shows the Pearson correlation analysis of the relationship between mH2A1.2 and LOX expression
Figure
Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer
Gangadharan, Nyirenda, Patel et al
Breast (2018) 39, 101-109 DOI: 10.1016/j.breast.2018.03.015
AI Summary: OriGene’s TissueScan Cancer Survey Panel and Breast Cancer Panel I-IV were used in this study to screen and analyze gene expression levels, including PIP, across a wide range of human cancer and breast cancer tissue samples.
Snippet: TissueScan Cancer Survey Panel (OriGene) was used for screening 18 different human cancer types (over 380 biospecimens), and Breast Cancer Panel I-IV (OriGene) was used for determining the expression levels of genes (approximately 150 biospecimens)
Showing 1-6 of 11 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products